BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome

Cynthia J. Sieben, Karthik B. Jeganathan, Grace G. Nelson, Ines Sturmlechner, Cheng Zhang, Willemijn H. Van Deursen, Bjorn Bakker, Floris Foijer, Hu Li, Darren J. Baker, Jan M. Van Deursen

Research output: Contribution to journalArticle

Abstract

Mosaic-variegated aneuploidy (MVA) syndrome is a rare childhood disorder characterized by biallelic BUBR1, CEP57, or TRIP13 aberrations; increased chromosome missegregation; and a broad spectrum of clinical features, including various cancers, congenital defects, and progeroid pathologies. To investigate the mechanisms underlying this disorder and its phenotypic heterogeneity, we mimicked the BUBR1L1012P mutation in mice (BubR1L1002P) and combined it with 2 other MVA variants, BUBR1X753 and BUBR1H, generating a truncated protein and low amounts of wild-type protein, respectively. Whereas BubR1X753/L1002P and BubR1H/X753 mice died prematurely, BubR1H/L1002P mice were viable and exhibited many MVA features, including cancer predisposition and various progeroid phenotypes, such as short lifespan, dwarfism, lipodystrophy, sarcopenia, and low cardiac stress tolerance. Strikingly, although these mice had a reduction in total BUBR1 and spectrum of MVA phenotypes similar to that of BubR1H/H mice, several progeroid pathologies were attenuated in severity, which in skeletal muscle coincided with reduced senescence-associated secretory phenotype complexity. Additionally, mice carrying monoallelic BubR1 mutations were prone to select MVA-related pathologies later in life, with predisposition to sarcopenia correlating with mTORC1 hyperactivity. Together, these data demonstrate that BUBR1 allelic effects beyond protein level and aneuploidy contribute to disease heterogeneity in both MVA patients and heterozygous carriers of MVA mutations.

Original languageEnglish (US)
Pages (from-to)171-188
Number of pages18
JournalJournal of Clinical Investigation
Volume130
Issue number1
DOIs
StatePublished - Jan 2 2020

Fingerprint

Progeria
Aneuploidy
Sarcopenia
Pathology
Phenotype
Mutation
Lipodystrophy
Dwarfism
Proteins
Mosaic variegated aneuploidy syndrome
Neoplasms
Skeletal Muscle
Chromosomes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome. / Sieben, Cynthia J.; Jeganathan, Karthik B.; Nelson, Grace G.; Sturmlechner, Ines; Zhang, Cheng; Van Deursen, Willemijn H.; Bakker, Bjorn; Foijer, Floris; Li, Hu; Baker, Darren J.; Van Deursen, Jan M.

In: Journal of Clinical Investigation, Vol. 130, No. 1, 02.01.2020, p. 171-188.

Research output: Contribution to journalArticle

Sieben, CJ, Jeganathan, KB, Nelson, GG, Sturmlechner, I, Zhang, C, Van Deursen, WH, Bakker, B, Foijer, F, Li, H, Baker, DJ & Van Deursen, JM 2020, 'BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome', Journal of Clinical Investigation, vol. 130, no. 1, pp. 171-188. https://doi.org/10.1172/JCI126863
Sieben CJ, Jeganathan KB, Nelson GG, Sturmlechner I, Zhang C, Van Deursen WH et al. BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome. Journal of Clinical Investigation. 2020 Jan 2;130(1):171-188. https://doi.org/10.1172/JCI126863
Sieben, Cynthia J. ; Jeganathan, Karthik B. ; Nelson, Grace G. ; Sturmlechner, Ines ; Zhang, Cheng ; Van Deursen, Willemijn H. ; Bakker, Bjorn ; Foijer, Floris ; Li, Hu ; Baker, Darren J. ; Van Deursen, Jan M. / BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome. In: Journal of Clinical Investigation. 2020 ; Vol. 130, No. 1. pp. 171-188.
@article{a6465b10104346d49850f0474fac9e47,
title = "BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome",
abstract = "Mosaic-variegated aneuploidy (MVA) syndrome is a rare childhood disorder characterized by biallelic BUBR1, CEP57, or TRIP13 aberrations; increased chromosome missegregation; and a broad spectrum of clinical features, including various cancers, congenital defects, and progeroid pathologies. To investigate the mechanisms underlying this disorder and its phenotypic heterogeneity, we mimicked the BUBR1L1012P mutation in mice (BubR1L1002P) and combined it with 2 other MVA variants, BUBR1X753 and BUBR1H, generating a truncated protein and low amounts of wild-type protein, respectively. Whereas BubR1X753/L1002P and BubR1H/X753 mice died prematurely, BubR1H/L1002P mice were viable and exhibited many MVA features, including cancer predisposition and various progeroid phenotypes, such as short lifespan, dwarfism, lipodystrophy, sarcopenia, and low cardiac stress tolerance. Strikingly, although these mice had a reduction in total BUBR1 and spectrum of MVA phenotypes similar to that of BubR1H/H mice, several progeroid pathologies were attenuated in severity, which in skeletal muscle coincided with reduced senescence-associated secretory phenotype complexity. Additionally, mice carrying monoallelic BubR1 mutations were prone to select MVA-related pathologies later in life, with predisposition to sarcopenia correlating with mTORC1 hyperactivity. Together, these data demonstrate that BUBR1 allelic effects beyond protein level and aneuploidy contribute to disease heterogeneity in both MVA patients and heterozygous carriers of MVA mutations.",
author = "Sieben, {Cynthia J.} and Jeganathan, {Karthik B.} and Nelson, {Grace G.} and Ines Sturmlechner and Cheng Zhang and {Van Deursen}, {Willemijn H.} and Bjorn Bakker and Floris Foijer and Hu Li and Baker, {Darren J.} and {Van Deursen}, {Jan M.}",
year = "2020",
month = "1",
day = "2",
doi = "10.1172/JCI126863",
language = "English (US)",
volume = "130",
pages = "171--188",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome

AU - Sieben, Cynthia J.

AU - Jeganathan, Karthik B.

AU - Nelson, Grace G.

AU - Sturmlechner, Ines

AU - Zhang, Cheng

AU - Van Deursen, Willemijn H.

AU - Bakker, Bjorn

AU - Foijer, Floris

AU - Li, Hu

AU - Baker, Darren J.

AU - Van Deursen, Jan M.

PY - 2020/1/2

Y1 - 2020/1/2

N2 - Mosaic-variegated aneuploidy (MVA) syndrome is a rare childhood disorder characterized by biallelic BUBR1, CEP57, or TRIP13 aberrations; increased chromosome missegregation; and a broad spectrum of clinical features, including various cancers, congenital defects, and progeroid pathologies. To investigate the mechanisms underlying this disorder and its phenotypic heterogeneity, we mimicked the BUBR1L1012P mutation in mice (BubR1L1002P) and combined it with 2 other MVA variants, BUBR1X753 and BUBR1H, generating a truncated protein and low amounts of wild-type protein, respectively. Whereas BubR1X753/L1002P and BubR1H/X753 mice died prematurely, BubR1H/L1002P mice were viable and exhibited many MVA features, including cancer predisposition and various progeroid phenotypes, such as short lifespan, dwarfism, lipodystrophy, sarcopenia, and low cardiac stress tolerance. Strikingly, although these mice had a reduction in total BUBR1 and spectrum of MVA phenotypes similar to that of BubR1H/H mice, several progeroid pathologies were attenuated in severity, which in skeletal muscle coincided with reduced senescence-associated secretory phenotype complexity. Additionally, mice carrying monoallelic BubR1 mutations were prone to select MVA-related pathologies later in life, with predisposition to sarcopenia correlating with mTORC1 hyperactivity. Together, these data demonstrate that BUBR1 allelic effects beyond protein level and aneuploidy contribute to disease heterogeneity in both MVA patients and heterozygous carriers of MVA mutations.

AB - Mosaic-variegated aneuploidy (MVA) syndrome is a rare childhood disorder characterized by biallelic BUBR1, CEP57, or TRIP13 aberrations; increased chromosome missegregation; and a broad spectrum of clinical features, including various cancers, congenital defects, and progeroid pathologies. To investigate the mechanisms underlying this disorder and its phenotypic heterogeneity, we mimicked the BUBR1L1012P mutation in mice (BubR1L1002P) and combined it with 2 other MVA variants, BUBR1X753 and BUBR1H, generating a truncated protein and low amounts of wild-type protein, respectively. Whereas BubR1X753/L1002P and BubR1H/X753 mice died prematurely, BubR1H/L1002P mice were viable and exhibited many MVA features, including cancer predisposition and various progeroid phenotypes, such as short lifespan, dwarfism, lipodystrophy, sarcopenia, and low cardiac stress tolerance. Strikingly, although these mice had a reduction in total BUBR1 and spectrum of MVA phenotypes similar to that of BubR1H/H mice, several progeroid pathologies were attenuated in severity, which in skeletal muscle coincided with reduced senescence-associated secretory phenotype complexity. Additionally, mice carrying monoallelic BubR1 mutations were prone to select MVA-related pathologies later in life, with predisposition to sarcopenia correlating with mTORC1 hyperactivity. Together, these data demonstrate that BUBR1 allelic effects beyond protein level and aneuploidy contribute to disease heterogeneity in both MVA patients and heterozygous carriers of MVA mutations.

UR - http://www.scopus.com/inward/record.url?scp=85077404131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077404131&partnerID=8YFLogxK

U2 - 10.1172/JCI126863

DO - 10.1172/JCI126863

M3 - Article

C2 - 31738183

AN - SCOPUS:85077404131

VL - 130

SP - 171

EP - 188

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -